By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Magle Chemoswed Holding AB (publ)

Magle Chemoswed Holding AB (publ) (MAGLE.ST)

STO Currency in SEK
kr 22.00
+kr 0.40
+1.85%
Last Update: 29 Aug 2025, 15:06
kr 451.35M
Market Cap
-43.68
P/E Ratio (TTM)
Forward Dividend Yield
kr 17.10 - kr 41.60
52 Week Range

MAGLE.ST Stock Price Chart

Explore Magle Chemoswed Holding AB (publ) interactive price chart. Choose custom timeframes to analyze MAGLE.ST price movements and trends.

MAGLE.ST Company Profile

Discover essential business fundamentals and corporate details for Magle Chemoswed Holding AB (publ) (MAGLE.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

30 Jun 2020

Employees

147.00

CEO

Justin Pierce

Description

Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care and diagnostics with a focus on products based on degradable starch microspheres. Its APIs include Warfarin sodium products that are used as anticoagulants for multiple indications; Melperone hydrochloride, which is an antipsychotic agent; Isradipine, a calcium channel blocker used to treat hypertension; Amantadine sulfate that is used in the treatment of central nervous system disorders; and Benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson's disease. The company also offers medical devices for applications in the areas of advanced wound care, surgical and diagnostics, and drug delivery comprising EmboCept S, a microsphere based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company's unique microsphere technology; SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures; and EmboCept M, a device for use in the treatment of benign prostatic hyperplasia. It serves companies in the pharmaceutical and medical device industry on a contract basis. The company was founded in 1944 and is headquartered in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.

MAGLE.ST Financial Timeline

Browse a chronological timeline of Magle Chemoswed Holding AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 1 Aug 2025

EPS came in at kr 0.10 matching the estimated kr 0.10, while revenue for the quarter reached kr 85.30M , meeting expectations.

Earnings released on 22 May 2025

EPS came in at -kr 0.07 falling short of the estimated kr 0.50 by -114.00%, while revenue for the quarter reached kr 81.37M , missing expectations by -8.16%.

Earnings released on 27 Mar 2025

EPS came in at -kr 0.04 falling short of the estimated kr 0.60 by -106.67%, while revenue for the quarter reached kr 87.22M , beating expectations by +4.46%.

Earnings released on 24 Oct 2024

EPS came in at kr 0.89 surpassing the estimated kr 0.20 by +345.00%, while revenue for the quarter reached kr 64.62M , missing expectations by -16.41%.

Earnings released on 18 Jul 2024

EPS came in at kr 0.01 falling short of the estimated kr 0.70 by -98.57%, while revenue for the quarter reached kr 45.98M , beating expectations by +5.45%.

Dividend declared on 26 Apr 2024

A dividend of kr 0.35 per share was announced, adjusted to kr 0.35. The dividend was paid on 3 May 2024.

Earnings released on 18 Apr 2024

EPS came in at kr 0.27 , while revenue for the quarter reached kr 38.22M .

Earnings released on 16 Feb 2024

EPS came in at kr 0.38 surpassing the estimated kr 0.10 by +280.00%, while revenue for the quarter reached kr 57.37M , beating expectations by +21.56%.

Earnings released on 25 Oct 2023

EPS came in at kr 0.05 falling short of the estimated kr 0.10 by -50.00%, while revenue for the quarter reached kr 40.30M , missing expectations by -3.59%.

Earnings released on 18 Jul 2023

EPS came in at kr 0.43 surpassing the estimated kr 0.10 by +336.40%, while revenue for the quarter reached kr 41.35M , missing expectations by -5.37%.

Earnings released on 31 Mar 2023

EPS came in at kr 0.27 surpassing the estimated kr 0.16 by +67.50%, while revenue for the quarter reached kr 41.21M , beating expectations by +7.84%.

Earnings released on 31 Dec 2022

EPS came in at kr 0.12 surpassing the estimated -kr 0.04 by +400.20%, while revenue for the quarter reached kr 41.01M , beating expectations by +17.09%.

Earnings released on 30 Sept 2022

EPS came in at kr 0.11 falling short of the estimated kr 0.16 by -32.44%, while revenue for the quarter reached kr 33.71M , missing expectations by -13.32%.

Earnings released on 30 Jun 2022

EPS came in at kr 0.35 surpassing the estimated -kr 0.08 by +540.25%, while revenue for the quarter reached kr 38.42M , beating expectations by +13.46%.

Earnings released on 31 Mar 2022

EPS came in at kr 0.27 surpassing the estimated -kr 0.03 by +989.33%, while revenue for the quarter reached kr 32.54M , missing expectations by -10.73%.

Earnings released on 31 Dec 2021

EPS came in at kr 0.09 , while revenue for the quarter reached kr 27.10M .

Earnings released on 30 Sept 2021

EPS came in at kr 0.14 falling short of the estimated kr 0.23 by -39.04%, while revenue for the quarter reached kr 37.17M , missing expectations by -11.48%.

Earnings released on 30 Jun 2021

EPS came in at kr 0.07 , while revenue for the quarter reached kr 36.48M .

Earnings released on 31 Mar 2021

EPS came in at kr 0.09 , while revenue for the quarter reached kr 30.43M .

Earnings released on 31 Dec 2020

EPS came in at -kr 0.07 , while revenue for the quarter reached kr 32.49M .

Stock split effective on 30 Nov 2020

Shares were split 127 : 125 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2020

EPS came in at -kr 0.04 , while revenue for the quarter reached kr 31.58M .

MAGLE.ST Stock Performance

Access detailed MAGLE.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run